PharmaShots | Incisive News in 3 Shots

Subscribe Now

Caliway Biopharmaceuticals

Caliway Reports the IND Acceptance of CBL-514 by the US FDA for the Treatment of Dercum's Disease

Caliway Reports the IND Acceptance of CBL-514 by the US FDA for the Treatment of Dercum's Disease

January 8, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us